Thus, the administration of cholecalciferol in post-dialytic phase contributes to the reduction of PTH levels [ ]. As PTH stimulates the renal 1-hydroxylation of 25 AME CF-2000 D [ 1 ], in patients with hypoparathyroidism the activation of vitamin D is impaired. Thus, the treatment of hypoparathyroidism should be based on the use of the active form of vitamin D, i. Alpha-calcidiol is AME CF-2000 available as tablets 0. We suggest the use of calcifediol in case of: Hepatic impairment;[…]
